Ferumoxytol is an iron-based substance that is used primarily in medications that treat anemia. However, the FDA recently cleared it for use in brain imaging as well.
The tool also can be used on contrasted abdominal scans completed for other clinical indications, offering providers an opportunity to address suspicious lesions before they progress.
The biggest investor in a nursing home chain can run but not hide from comeuppance for the chain’s alleged role in harms—including deaths—done to hundreds of patients.
Cytokinetics has secured FDA approval for aficamten, its new drug for the treatment of symptomatic obstructive HCM. Aficamten will be sold under the brand name Myqorzo.
PAD in patients with diabetes is common and associated with an increased risk of several adverse events. A new guidance from the American College of Cardiology reviewed this topic at length, identifying areas where care needs to improve.
One of the event's primary takeaways was that interventional cardiology does still attract a healthy number of trainees. However, SCAI sees several ways the specialty can improve to be even more appealing in the future.
PFA has emerged as the preferred ablation strategy for many electrophysiologists, but some questions do remain about its long-term impact. HRS is developing this new registry to be as user-friendly for clinicians as possible.
“Physical AI agents being able to actually deliver some of these services—all the way into robotic surgery—this is where we're going to see this next chapter of medicine be written,” said Kimberly Powell, vice president and general manager of healthcare at NVIDIA.
Fairfax Radiological Consultants, located in the D.C. metro area, had employed over 500 individuals as of 2019, but by April 2020, its roster was down to fewer than 100, the DOJ note.
Ferumoxytol is an iron-based substance that is used primarily in medications that treat anemia. However, the FDA recently cleared it for use in brain imaging as well.
The tool also can be used on contrasted abdominal scans completed for other clinical indications, offering providers an opportunity to address suspicious lesions before they progress.
The biggest investor in a nursing home chain can run but not hide from comeuppance for the chain’s alleged role in harms—including deaths—done to hundreds of patients.
